137 related articles for article (PubMed ID: 33331219)
1. An unusual case of coma related to glutamate receptor 3 (GluR3) auto-antibodies after a traumatic spinal cord injury: Clinical and pathological aspects.
Caputo F; Barranco R; Ricci P; Gratteri S; Castelletti L; Ravetti GL; Ventura F
Med Leg J; 2021 Jun; 89(2):133-136. PubMed ID: 33331219
[TBL] [Abstract][Full Text] [Related]
2. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.
Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T
J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050
[TBL] [Abstract][Full Text] [Related]
5. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings.
Ricken G; Zrzavy T; Macher S; Altmann P; Troger J; Falk KK; Kiefer A; Fichtenbaum A; Mitulovic G; Kubista H; Wandinger KP; Rommer P; Bartsch T; Berger T; Weber J; Leypoldt F; Höftberger R
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34016735
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
Levite M; Ganor Y
Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
[TBL] [Abstract][Full Text] [Related]
8. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A
Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's encephalitis associated with AMPAR2 antibodies: a case report.
Zhu M; Yu X; Liu C; Duan C; Li C; Zhu J; Zhang Y
BMC Neurol; 2017 Feb; 17(1):37. PubMed ID: 28222692
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
[TBL] [Abstract][Full Text] [Related]
12. No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3--antibodies.
Feichtinger M; Wiendl H; Körner E; Holl A; Gruber L; Fazekas F; Schröttner O; Eder H; Ott E
Seizure; 2006 Jul; 15(5):350-4. PubMed ID: 16621617
[TBL] [Abstract][Full Text] [Related]
13. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
14. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy and the immune system.
Aarli JA
Arch Neurol; 2000 Dec; 57(12):1689-92. PubMed ID: 11115234
[TBL] [Abstract][Full Text] [Related]
16. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
17. Pulvinar sign in a case of anti-CV2 encephalitis.
Fadda L; Floris G; Polizzi L; Meleddu L; Ercoli T; Garofalo P; Saba L; Muroni A; Defazio G
J Neurol Sci; 2018 Oct; 393():69-71. PubMed ID: 30121006
[No Abstract] [Full Text] [Related]
18. [Anti-NMDA receptor encephalitis: two paediatric cases].
González-Toro MC; Jadraque-Rodríguez R; Sempere-Pérez Á; Martínez-Pastor P; Jover-Cerdá J; Gómez-Gosálvez F
Rev Neurol; 2013 Dec; 57(11):504-8. PubMed ID: 24265144
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.
Cohen-Kashi Malina K; Ganor Y; Levite M; Teichberg VI
Neurochem Res; 2006 Oct; 31(10):1181-90. PubMed ID: 16967334
[TBL] [Abstract][Full Text] [Related]
20. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.
Whitney KD; McNamara JO
J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
